M4MM
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The final days of July and the opening of August delivered a concentrated burst of news that touched labor, capital markets, federal regulation, and cross-border insolvency. A historic labor settlement, a one-company ...
MJBowl Adds Colorado for Its Second Year
LOS ANGELES – The MJBowl, the Cannabis product competition co-presented by MJBizCon and professional review platform Budist, is returning for its second year, with Colorado joining California and New York in the competition pool for ...
FDA Issues Final Guidance on Psychedelic Drug Trials
SILVER SPRING – The FDA published its final guidance titled "Psychedelic Drugs: Considerations for Clinical Investigations" in the Federal Register, finalizing a draft that first appeared in June 2023. Issued by the Center for Drug ...
North Carolina Lawmakers Unite Behind Psychedelic Research Bill for Veterans
RALEIGH – NC Lawmakers from both parties held a press conference at the General Assembly to support legislation that would direct state funding toward research on psilocybin, MDMA, and ibogaine as treatments for PTSD and ...
Glass House Brands Applies for NYSE Uplisting
LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among ...
Virginia Governor and Lawmakers Announce Agreement on Legal Cannabis Sales
RICHMOND – Governor Abigail Spanberger, State Senator Lashrecse Aird (D), and Delegate Paul Krizek (D), announced they had reached a compromise to establish a legal, regulated retail cannabis market. This marks the culmination of a ...
Splash Beverage Group Completes Strategic Investment in Avicanna, Transforms into Cannabinoid Healthcare
FORT LAUDERDALE – Splash Beverage Group Inc. announced the completion of a CDN$300,000 (~USD$217,479) minority investment in Avicanna Inc., a commercial-stage international biopharmaceutical company headquartered in Toronto, Canada. The transaction involved Splash acquiring 2,000,000 common ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The final days of July and the opening of August delivered a concentrated burst of news that touched labor, capital markets, federal regulation, and cross-border insolvency. A historic labor settlement, a one-company ...
MJBowl Adds Colorado for Its Second Year
LOS ANGELES – The MJBowl, the Cannabis product competition co-presented by MJBizCon and professional review platform Budist, is returning for its second year, with Colorado joining California and New York in the competition pool for ...
FDA Issues Final Guidance on Psychedelic Drug Trials
SILVER SPRING – The FDA published its final guidance titled "Psychedelic Drugs: Considerations for Clinical Investigations" in the Federal Register, finalizing a draft that first appeared in June 2023. Issued by the Center for Drug ...
Psilocybin Shows Promise for Traumatic Brain Injury Recovery
LOS ANGELES – A scientific review published in the journal Brain Sciences has outlined how psilocybin, the active compound in psychedelic mushrooms, might support recovery for individuals with traumatic brain injuries. The analysis, released in ...
Cannabis Companies Secure Extension in Federal Prohibition Case
WASHINGTON – The U.S. Supreme Court has extended the deadline for a group of Cannabis businesses to file a petition seeking review of their case against the Justice Department, which aims to strike down the ...
NYC Dispensaries Seek Justice in Court Over Schools Proximity Blunder
NEW YORK – A coalition of licensed Cannabis dispensaries filed suit against New York regulators on Friday, claiming a state error in enforcing school buffer zones threatens their operations and could force closures or costly ...
Cannabist Finalizes Pennsylvania Dispensary Sale, Prioritizing Wholesale Model
NEW YORK – The Cannabist Company Holdings Inc., a major player in the U.S. Cannabis sector, has completed the sale of its Pennsylvania retail operations for $10 million in cash. The buyer, VP Investment Holdings ...
Rubicon Organics Reports Q2 2025 Financial Results
VANCOUVER, BC – Rubicon Organics Inc., a leading Canadian producer of premium organic Cannabis, announced financial results for the second quarter ending June 30, 2025. The company reported net revenue of $15 million, a 24% ...
Week In Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Lively discussions were fueled last week by policy developments, financial reports, and strategic expansions in the Cannabis and Psychedelics industries. From federal rescheduling debates to global market moves, the Highly Capitalized Network ...
A LIFE IN A DAY: David Peck, CEO of Headquarters
LOS ANGELES- In this edition of A LIFE IN A DAY, Highly Capitalized Network catches up with David Peck, the founder and CEO of Headquarters (HQ)—an operations partner for Cannabis businesses across the country. Headquarters ...
Glass House Brands Reports Q2 2025 Financial Results
LONG BEACH and TORONTO – Glass House Brands Inc., a leading vertically integrated Cannabis operator in the US, unveiled its second-quarter 2025 financial statements, showing impressive growth in key areas despite ongoing market pressures and ...
Psychedelics Market Set to Reach $22.6 Billion by 2033, Report Finds
NEW YORK – A recent report by Research and Markets reveals the current global psychedelic drugs market is valued at $7.4 billion and is projected to hit $22.6 billion by 2033, exhibiting a substantial compound ...
High Tide Enters German Medical Cannabis Market with Remexian Majority Stake Acquisition
CALGARY – High Tide Inc., a leading Canadian Cannabis retailer, announced its strategic entry into Germany’s medical Cannabis market through a 51% acquisition of Remexian Pharma GmbH, a Frankfurt-based pharmaceutical wholesaler. The deal, valued at ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
Cresco Labs Strengthens Financial Position with $325 Million Senior Secured Term Loan Refinancing
CHICAGO – Cresco Labs Inc. announced the closing of a significant refinancing transaction, marking a strategic move towards long-term balance sheet stability. The company successfully replaced its previous $360 million senior secured credit facility with ...
Planet 13 Reports Q2 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a vertically integrated multi-state Cannabis operator, released its Q2 2025 financial results, reflecting a challenging quarter marked by market pressures and strategic adjustments. The company reported revenue of ...
Organigram Reports Q3 FY2025 Financial Results
TORONTO – Organigram Global Inc. announced record financial results for its third quarter of fiscal 2025, ending June 30, 2025. The company achieved significant growth in revenue and adjusted EBITDA, driven by strategic acquisitions and ...
Cannabis MSOs Face High-Stakes Tax Dilemma as Rescheduling Decision Looms Under Trump
As Trump's administration weighs reclassifying Cannabis to Schedule III, Cannabis giants continue to contend with hefty uncertain tax liabilities under IRS Section 280E, a rule that has long hampered their financial flexibility. A recent report ...
